ARQT — ARCUTIS BIOTHERAPEUTICS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 283 SEC-registered investment managers reported holding ARQT (ARCUTIS BIOTHERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $3.55B across 135.38M shares. That is -1.7% by share count (-2.17M shares) versus the previous quarter, while reported value moved +9.7%. Ownership is concentrated: the five largest holders account for 35.3% of reported value and the top ten for 51.2%.
Compared with the prior quarter, 44 opened new positions, 93 added to existing stakes, 105 trimmed, 42 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of ARCUTIS BIOTHERAPEUTICS INC (ARQT) include BlackRock Inc, MONTANOVA CAPITAL, LLC, Frazier Life Sciences Management, L.P., ranked by reported 13F value among the 521 institutional holders on this page.
ARQT is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 211 | 78.51M | $2.09B | +29.0% |
| Q2 2026 | 283 | 135.38M | $3.55B | -1.5% |
| Q1 2026 | 280 | 137.69M | $3.23B | +1.3% |
| Q4 2025 | 292 | 135.06M | $3.89B | +0.6% |
| Q3 2025 | 245 | 129.20M | $2.43B | -1.3% |
| Q2 2025 | 234 | 131.78M | $1.84B | +4.0% |
| Q1 2025 | 243 | 129.25M | $2.01B | -8.3% |
| Q4 2024 | 207 | 135.78M | $1.99B | +4.7% |
Over the 8 quarters shown, institutional share counts decreased 42% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q1 2025 (-8.3%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 19.17M | $506.69M | 0.01% | Add | |
| 7.72M | $204.00M | 0.01% | Add | |
| 5.53M | $146.24M | 0.06% | Add | |
| 5.30M | $139.99M | 0.01% | Add | |
| 4.99M | $131.99M | 0.00% | Hold | |
| 3.82M | $100.90M | 0.01% | Add | |
| 2.97M | $78.53M | 0.00% | Hold | |
| 1.98M | $67.36M | 0.01% | Add | |
| 1.98M | $52.22M | 0.02% | Add | |
| 1.35M | $35.75M | 0.30% | Add | |
| 1.20M | $31.85M | 0.04% | Add | |
| 1.17M | $30.81M | 0.04% | Add | |
| 1.01M | $26.65M | 10.86% | Reduce | |
| 1.00M | $26.63M | 0.12% | Add | |
| 958.84K | $25.34M | 0.39% | Reduce | |
| 873.55K | $23.09M | 0.04% | Reduce | |
| 865.86K | $22.88M | 0.38% | New | |
| 814.48K | $21.53M | 0.01% | Hold | |
| 813.89K | $21.51M | 0.02% | Hold | |
| 803.52K | $21.24M | 0.01% | Add | |
| 776.83K | $20.53M | 0.08% | Add | |
| 769.78K | $20.35M | 0.01% | Reduce | |
| 774.31K | $20.33M | 0.05% | New | |
| 709.62K | $18.76M | 0.09% | Add | |
| 597.12K | $15.78M | 1.27% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 12.44M | $326.10M | 5.96% | Add | |
| 10.55M | $276.50M | 0.01% | Add | |
| 9.87M | $258.91M | 5.64% | Hold | |
| 8.27M | $216.88M | 2.00% | Hold | |
| 6.61M | $173.23M | 0.50% | Add | |
| 4.99M | $130.81M | 0.00% | Add | |
| 4.45M | $116.71M | 0.01% | Add | |
| 4.22M | $110.62M | 0.07% | Reduce | |
| 3.95M | $103.56M | 0.05% | Add | |
| 3.95M | $103.56M | 0.15% | Add | |
| 3.33M | $87.39M | 0.04% | Hold | |
| 2.99M | $78.33M | 0.01% | Add | |
| 2.98M | $78.21M | 0.00% | New | |
| 2.98M | $78.21M | 0.00% | Reduce | |
| 2.43M | $63.69M | 0.00% | Add | |
| 2.04M | $53.54M | 1.08% | New | |
| 1.93M | $50.63M | 0.01% | Reduce | |
| 1.93M | $50.47M | 0.02% | Add | |
| 1.67M | $43.74M | 0.01% | Add | |
| 1.41M | $36.99M | 0.01% | New | |
| 1.37M | $36.00M | 0.74% | Add | |
| 1.31M | $34.43M | 0.35% | Reduce | |
| 1.29M | $33.77M | 0.26% | Add | |
| 1.27M | $33.18M | 10.78% | Reduce | |
| 1.25M | $32.86M | 0.08% | Add |
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 12.33M | $290.42M | 7.42% | Add | |
| 9.87M | $232.64M | 5.99% | Hold | |
| 9.20M | $216.76M | 0.01% | Add | |
| 8.27M | $194.88M | 2.08% | Hold | |
| 6.30M | $148.34M | 0.01% | Add | |
| 5.67M | $133.51M | 0.59% | Add | |
| 4.98M | $117.35M | 0.08% | Reduce | |
| 4.87M | $114.77M | 0.00% | New | |
| 4.30M | $101.40M | 1.22% | Reduce | |
| 4.22M | $99.40M | 0.01% | Reduce | |
| 3.33M | $78.44M | 0.04% | Add | |
| 3.05M | $71.76M | 0.00% | Add | |
| 2.50M | $58.81M | 0.04% | Reduce | |
| 2.50M | $58.81M | 0.11% | Reduce | |
| 2.43M | $57.29M | 0.09% | Add | |
| 2.30M | $54.14M | 0.01% | Add | |
| 2.23M | $52.45M | 0.39% | Reduce | |
| 2.22M | $52.33M | 0.00% | Add | |
| 1.95M | $46.05M | 0.00% | New | |
| 1.85M | $43.68M | 0.02% | Add | |
| 1.60M | $37.77M | 0.01% | Add | |
| 1.46M | $34.47M | 0.02% | Hold | |
| 1.37M | $32.18M | 0.95% | Add | |
| 1.36M | $31.94M | 11.42% | Reduce | |
| 1.24M | $29.32M | 0.06% | Reduce |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 11.96M | $347.43M | 7.12% | Add | |
| 9.87M | $286.76M | 7.70% | Hold | |
| 9.10M | $264.25M | 0.01% | Add | |
| 8.27M | $240.21M | 2.89% | Reduce | |
| 7.25M | $210.65M | 0.00% | Add | |
| 6.76M | $196.25M | 0.12% | Reduce | |
| 5.56M | $161.35M | 0.75% | Add | |
| 5.49M | $159.38M | 0.01% | Add | |
| 4.45M | $129.34M | 1.36% | Add | |
| 4.34M | $126.04M | 0.01% | Add | |
| 3.24M | $94.19M | 0.05% | Add | |
| 2.75M | $79.97M | 0.01% | Add | |
| 2.68M | $77.92M | 0.05% | Add | |
| 2.68M | $77.92M | 0.15% | Add | |
| 2.56M | $74.41M | 0.51% | Add | |
| 1.90M | $55.25M | 0.10% | Reduce | |
| 1.90M | $55.18M | 0.02% | Reduce | |
| 1.83M | $53.15M | 0.02% | Reduce | |
| 1.67M | $48.60M | 0.00% | Add | |
| 1.58M | $45.78M | 0.02% | Reduce | |
| 1.47M | $42.61M | 0.02% | Reduce | |
| 1.38M | $40.14M | 0.01% | Add | |
| 1.37M | $39.69M | 15.34% | Reduce | |
| 1.17M | $33.87M | 0.00% | Add | |
| 1.01M | $29.47M | 0.01% | Add |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 12.25M | $230.99M | 0.13% | Add | |
| 10.75M | $202.63M | 2.31% | Hold | |
| 10.48M | $197.51M | 5.11% | Reduce | |
| 9.87M | $186.13M | 5.58% | Hold | |
| 8.57M | $161.62M | 0.00% | Hold | |
| 7.15M | $134.70M | 0.00% | Add | |
| 5.30M | $99.88M | 0.52% | Add | |
| 4.64M | $87.49M | 0.00% | Add | |
| 4.43M | $83.49M | 0.85% | Add | |
| 4.28M | $80.61M | 0.01% | Reduce | |
| 2.95M | $55.58M | 0.03% | Hold | |
| 2.61M | $49.14M | 0.00% | Add | |
| 2.40M | $45.18M | 0.02% | Add | |
| 2.31M | $43.56M | 0.01% | Reduce | |
| 2.12M | $39.97M | 23.11% | Hold | |
| 2.12M | $39.94M | 0.08% | Reduce | |
| 2.12M | $39.94M | 0.03% | Reduce | |
| 2.02M | $38.16M | 0.47% | Add | |
| 1.99M | $37.57M | 0.06% | Hold | |
| 1.80M | $34.02M | 0.01% | Reduce | |
| 1.66M | $31.34M | 0.02% | Reduce | |
| 1.37M | $25.83M | 0.01% | Add | |
| 1.17M | $22.09M | 0.20% | Reduce | |
| 1.10M | $20.68M | 0.15% | Add | |
| 999.43K | $18.84M | 0.00% | Add |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 11.54M | $161.73M | 4.99% | Add | |
| 11.11M | $155.75M | 0.09% | Reduce | |
| 10.75M | $150.71M | 2.30% | Reduce | |
| 9.87M | $138.44M | 5.54% | Add | |
| 8.53M | $119.63M | 0.00% | Reduce | |
| 7.05M | $98.83M | 0.00% | Add | |
| 5.01M | $70.19M | 0.37% | Reduce | |
| 4.53M | $63.47M | 0.00% | Add | |
| 4.31M | $60.49M | 0.00% | Add | |
| 4.16M | $58.26M | 0.62% | Add | |
| 2.94M | $41.19M | 0.03% | Add | |
| 2.73M | $38.31M | 0.01% | Reduce | |
| 2.58M | $36.21M | 0.00% | Add | |
| 2.26M | $31.76M | 0.02% | Add | |
| 2.16M | $30.33M | 0.07% | Add | |
| 2.16M | $30.33M | 0.02% | Add | |
| 2.12M | $29.73M | 18.43% | Hold | |
| 2.00M | $28.06M | 0.05% | Add | |
| 1.89M | $26.50M | 0.01% | Add | |
| 1.72M | $24.17M | 0.01% | Add | |
| 1.49M | $20.83M | 0.10% | Add | |
| 1.38M | $19.33M | 0.17% | Reduce | |
| 1.20M | $16.86M | 0.00% | Add | |
| 1.09M | $15.23M | 0.12% | Reduce | |
| 1.00M | $14.02M | 1.04% | Reduce |
New Positions (Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 2.98M sh · $78.21M
- ORBIMED ADVISORS LLC 2.04M sh · $53.54M
- Jupiter Topco LLC 1.41M sh · $36.99M
- Jones Hill Capital LP 1.09M sh · $28.57M
- Sixth Street Partners Management Company, L.P. 1.05M sh · $27.56M
- Longaeva Partners L.P. 344.80K sh · $9.04M
- Balyasny Asset Management 243.12K sh · $6.37M
- PFM Health Sciences, LP 242.07K sh · $6.35M
- Holocene Advisors, LP 163.73K sh · $4.29M
- TUDOR INVESTMENT CORP ET AL 131.91K sh · $3.46M
- JACOBS LEVY EQUITY MANAGEMENT, INC 86.03K sh · $2.26M
- Y-Intercept (Hong Kong) Ltd 75.57K sh · $1.98M
Fully Exited (vs previous quarter)
- STATE STREET CORP sold 6.30M sh · $148.34M
- Janus Henderson Group sold 1.85M sh · $43.68M
- MPM BioImpact LLC sold 733.97K sh · $17.29M
- M&G Plc sold 469.08K sh · $11.26M
- ZEVENBERGEN CAPITAL INVESTMENTS LLC sold 357.49K sh · $8.42M
- Penn Capital Management Company, LLC sold 333.13K sh · $7.86M
- Hillsdale Investment Management Inc. sold 188.22K sh · $4.43M
- NORDEA INVESTMENT MANAGEMENT AB sold 192.92K sh · $4.41M
- Jackson Creek Investment Advisors LLC sold 68.65K sh · $1.62M
- Engineers Gate Manager LP sold 65.98K sh · $1.55M
- Invst, LLC sold 35.20K sh · $829.43K
- Campbell & CO Investment Adviser LLC sold 31.54K sh · $743.18K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | 19.17M | 10.55M | 9.20M | 9.10M | 8.57M | 8.53M | 8.89M | 9.15M | 9.03M | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 7.72M | — | 6.30M | 5.49M | 4.64M | 4.53M | 4.47M | 4.95M | 5.64M | 5.13M | 8.78M | 1.53M | 4.36M | — | — | — | — | — | — | — |
| UBS Group AG | 5.53M | 3.33M | 3.33M | 3.24M | 2.95M | 2.94M | 2.92M | 2.79M | 220.19K | 309.57K | 490.68K | 2.10K | 64.14K | 139.75K | 88.78K | 193.31K | 23.57K | 16.72K | 54.30K | 54.66K |
| Morgan Stanley | 5.30M | 4.45M | 4.22M | 4.34M | 4.28M | 4.31M | 3.84M | 4.24M | 3.78M | 3.97M | 4.01M | 6.08M | 222.04K | 485.98K | 337.65K | 198.06K | 124.93K | 108.17K | 97.45K | 53.02K |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.99M | 4.99M | 4.87M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.82M | 2.43M | 1.95M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 2.97M | 2.98M | 3.05M | 2.75M | 2.61M | 2.58M | 2.55M | 2.47M | 2.47M | 2.42M | 1.97M | 1.74M | 1.04M | 937.45K | 808.37K | 779.14K | 734.24K | 568.67K | 509.38K | 489.34K |
| Franklin Resources | 1.98M | 1.93M | 2.30M | 1.90M | 2.31M | 2.73M | 2.76M | 3.31M | 4.25M | 4.44M | 4.64M | 4.66M | 1.29M | 1.65M | 1.59M | 797.74K | 799.00K | 793.90K | 659.84K | 615.75K |
| AMERICAN CENTURY COMPANIES INC | 1.98M | 1.93M | 1.46M | 1.47M | 1.66M | 1.72M | 1.65M | 1.63M | 1.46M | 1.23M | 1.04M | 911.80K | 510.09K | — | — | — | — | — | — | — |
| GW&K Investment Management, LLC | 1.35M | 1.29M | 988.39K | 1.01M | 1.17M | 1.38M | 1.51M | 1.54M | 1.59M | 1.67M | 1.72M | 1.64M | 2.07M | — | — | — | — | — | — | — |
| Aberdeen Group plc | 1.20M | 1.10M | 645.07K | 586.40K | 675.03K | 675.03K | 587.54K | 482.07K | 482.07K | 148.87K | 148.87K | 148.87K | — | — | — | — | — | — | — | — |
| FEDERATED HERMES, INC. | 1.17M | 1.12M | 1.08M | 891.77K | 759.57K | 737.37K | 737.55K | 492.92K | 501.83K | 350.11K | 350.11K | 521.47K | 60.00K | — | — | — | — | — | — | — |
| Pivotal bioVenture Partners Investment Advisor LLC | 1.01M | 1.27M | 1.36M | 1.37M | 2.12M | 2.12M | 2.12M | 2.12M | 2.12M | 2.04M | 2.03M | 1.91M | 1.11M | — | — | — | — | — | — | — |
| Candriam S.C.A. | 1.00M | 949.84K | 1.09M | 803.14K | 778.04K | 790.43K | 1.04M | 1.04M | 1.43M | 1.31M | — | — | — | — | — | — | — | — | — | — |
| Perpetual Ltd | 958.84K | 1.11M | 909.55K | 910.63K | 2.02M | 26.52K | 26.52K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Ensign Peak Advisors, Inc | 873.55K | 974.53K | 1.24M | 1.90M | 1.99M | 2.00M | 1.99M | 2.37M | 2.42M | 2.13M | 2.98M | 2.03M | 826.10K | — | — | — | — | — | — | — |
| Simplify Asset Management Inc. | 865.86K | — | — | — | 318.00K | 409.43K | 660.56K | 742.30K | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 814.48K | 815.14K | 771.76K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Manulife Financial | 813.89K | 811.75K | 503.86K | 125.98K | 56.02K | 57.95K | 58.09K | 50.96K | 52.50K | 40.32K | 30.79K | 33.51K | 21.04K | 21.04K | 16.39K | 17.07K | 14.23K | 14.15K | 12.22K | 15.43K |
| Principal Global Investors | 803.52K | 183.66K | 168.83K | — | — | — | — | — | — | 18.55K | 19.12K | 18.42K | 15.08K | 14.94K | 13.38K | 14.36K | 11.71K | 11.09K | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold ARQT?
As of 2026-Q2, 283 institutional funds reported holding ARQT (ARCUTIS BIOTHERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $3.55B.
How many shares of ARQT do institutions own?
13F filers reported 135.38M shares of ARQT, worth $3.55B in aggregate at the end of 2026-Q2.
Is institutional ownership of ARQT rising or falling?
Share counts moved -1.7% versus the prior quarter — distribution.
Who are the top institutional holders of ARQT?
The largest 13F holders are BlackRock Inc, MONTANOVA CAPITAL, LLC, Frazier Life Sciences Management, L.P., Rubric Capital Management LP, Vanguard Group; the top 25 are ranked at the top of this page.
Who are the major shareholders of ARCUTIS BIOTHERAPEUTICS INC?
The major shareholders of ARCUTIS BIOTHERAPEUTICS INC (ARQT) by reported 13F value are BlackRock Inc, MONTANOVA CAPITAL, LLC, Frazier Life Sciences Management, L.P., Rubric Capital Management LP, Vanguard Group, among 521 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.